Literature DB >> 11884384

Structure of the carboxyl-terminal Src kinase, Csk.

Akira Ogawa1, Yoshiharu Takayama, Hiroaki Sakai, Khoon Tee Chong, Satoru Takeuchi, Atsushi Nakagawa, Shigeyuki Nada, Masato Okada, Tomitake Tsukihara.   

Abstract

The carboxyl-terminal Src kinase (Csk) is an indispensable negative regulator for the Src family tyrosine kinases (SFKs) that play pivotal roles in various cell signalings. To understand the molecular basis of the Csk-mediated regulation of SFKs, we elucidated the crystal structure of full-length Csk. The Csk crystal consists of six molecules classified as active or inactive states according to the coordinations of catalytic residues. Csk assembles the SH2 and SH3 domains differently from inactive SFKs, and their binding pockets are oriented outward enabling the intermolecular interaction. In active molecules, the SH2-kinase and SH2-SH3 linkers are tightly stuck to the N-lobe of the kinase domain to stabilize the active conformation, and there is a direct linkage between the SH2 and the kinase domains. In inactive molecules, the SH2 domains are rotated destroying the linkage to the kinase domain. Cross-correlation matrices for the active molecules reveal that the SH2 domain and the N-lobe of the kinase domain move as a unit. These observations suggest that Csk can be regulated through coupling of the SH2 and kinase domains and that Csk provides a novel built-in activation mechanism for cytoplasmic tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884384     DOI: 10.1074/jbc.C200086200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Loops govern SH2 domain specificity by controlling access to binding pockets.

Authors:  Tomonori Kaneko; Haiming Huang; Bing Zhao; Lei Li; Huadong Liu; Courtney K Voss; Chenggang Wu; Martin R Schiller; Shawn Shun-Cheng Li
Journal:  Sci Signal       Date:  2010-05-04       Impact factor: 8.192

2.  Disrupting the intermolecular self-association of Itk enhances T cell signaling.

Authors:  Lie Min; Wenfang Wu; Raji E Joseph; D Bruce Fulton; Leslie Berg; Amy H Andreotti
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

3.  Overlap between folding and functional energy landscapes for adenylate kinase conformational change.

Authors:  Ulrika Olsson; Magnus Wolf-Watz
Journal:  Nat Commun       Date:  2010-11-16       Impact factor: 14.919

4.  Conformational transitions of adenylate kinase: switching by cracking.

Authors:  Paul C Whitford; Osamu Miyashita; Yaakov Levy; José N Onuchic
Journal:  J Mol Biol       Date:  2006-12-05       Impact factor: 5.469

5.  Leucine motif-dependent tyrosine autophosphorylation of type III receptor tyrosine kinases.

Authors:  Rosana D Meyer; Xiaofeng Qian; Hwai-Chen Guo; Nader Rahimi
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

6.  SRC family kinases and receptors: analysis of three activation mechanisms by dynamic systems modeling.

Authors:  Hendrik Fuss; Werner Dubitzky; C Stephen Downes; Mary Jo Kurth
Journal:  Biophys J       Date:  2007-11-30       Impact factor: 4.033

7.  Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states.

Authors:  Irina Kufareva; Ruben Abagyan
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

8.  Mapping the conformational transition in Src activation by cumulating the information from multiple molecular dynamics trajectories.

Authors:  Sichun Yang; Nilesh K Banavali; Benoît Roux
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

9.  Achieving a Graded Immune Response: BTK Adopts a Range of Active/Inactive Conformations Dictated by Multiple Interdomain Contacts.

Authors:  Raji E Joseph; Thomas E Wales; D Bruce Fulton; John R Engen; Amy H Andreotti
Journal:  Structure       Date:  2017-08-31       Impact factor: 5.006

10.  Conformational snapshots of Tec kinases during signaling.

Authors:  Raji E Joseph; Amy H Andreotti
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.